Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,615
Closed -$312K 271
2026
Q1
$312K Sell
2,615
-805
-24% -$106K 0.11% 163
2025
Q4
$466K Sell
3,420
-184
-5% -$26.5K 0.15% 118
2025
Q3
$532K Buy
3,604
+61
+2% +$8.46K 0.18% 102
2025
Q2
$458K Buy
3,543
+63
+2% +$7.63K 0.17% 112
2025
Q1
$416K Buy
3,480
+19
+0.5% +$2.35K 0.16% 112
2024
Q4
$402K Buy
3,461
+713
+26% +$90.1K 0.15% 114
2024
Q3
$371K Sell
2,748
-12
-0.4% -$1.6K 0.16% 117
2024
Q2
$374K Buy
2,760
+281
+11% +$38.2K 0.17% 114
2024
Q1
$320K Hold
2,479
0.16% 123
2023
Q4
$283K Buy
+2,479
New +$247K 0.17% 118

Other funds holding XYL

Canopy Partners's XYL Position: Q2 2026 in Review

Canopy Partners sold out of Xylem (XYL) in Q2 2026, closing a stake of 2,615 shares — an estimated $312K sold.

Canopy Partners first reported a position in XYL in Q4 2023 and held it in 10 quarters. The position peaked at $532K in Q3 2025. 248 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Canopy Partners reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Canopy Partners sold 2,615 Xylem shares in Q2 2026, an estimated $312K.
  • Canopy Partners first reported a position in Xylem in Q4 2023 and held it in 10 quarters.
  • Canopy Partners's Xylem position peaked at $532K in Q3 2025.
  • 248 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.